首页> 外国专利> MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS

MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS

机译:包含S1P脂质的标记组合物,可预测骨质疏松性骨折和骨质疏松的风险

摘要

Disclosed herein is a marker composition that includes sphingosine 1-phosphate (S1P) lipid and that may be used to predict the risk of fracture or osteoporosis; a kit that includes an antibody that specifically binds to the S1P lipid and that can be used to predict the risk of fracture or osteoporosis; and a method that can be used to obtain information that allows prediction of the risk of fracture or osteoporosis and includes measurements of S1P lipid concentrations by measuring the binding of a S1P-specific antibody to SIP lipid. The S1P lipid disclosed herein is highly expressed in individuals with fracture, regardless of their bone mineral density. Accordingly, it may be useful as a biomarker of the risk of fracture or osteoporosis.
机译:本文公开了一种标记物组合物,其包括1-磷酸鞘氨醇(S1P)脂质,并且可以用于预测骨折或骨质疏松的风险;一种试剂盒,其中包含与S1P脂质特异性结合的抗体,可用于预测骨折或骨质疏松的风险;以及可用于获得允许预测骨折或骨质疏松风险的信息的方法,该方法包括通过测量S1P特异性抗体与SIP脂质的结合来测量S1P脂质浓度。本文公开的S1P脂质在骨折个体中高表达,无论其骨矿物质密度如何。因此,它可用作骨折或骨质疏松症风险的生物标志物。

著录项

  • 公开/公告号US2018209996A1

    专利类型

  • 公开/公告日2018-07-26

    原文格式PDF

  • 申请/专利权人 THE ASAN FOUNDATION;

    申请/专利号US201815927459

  • 申请日2018-03-21

  • 分类号G01N33/92;C07K16/18;C07K14/47;G01N33/68;

  • 国家 US

  • 入库时间 2022-08-21 12:58:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号